| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$2,165 ) |
| | 2027 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AG087622 | Determining the influence of metformin treatment on mitochondrial calcium flux during aerobic exercise training of healthy, aging rats | 000 | 2 | NIH | 10/27/2026 | -$2,165 |
|
| Issue Date FY: 2026 ( Subtotal = $42,589,106 ) (Continued on the next page) |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM156711 | Center for Genomic Regulation | 000 | 2 | NIH | 6/3/2026 | $2,463,036 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL148123 | The Role of TGF-beta Activation and Signaling in Aortic Stenosis Progression | 000 | 5 | NIH | 8/21/2026 | $436,750 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL148123 | The Role of TGF-beta Activation and Signaling in Aortic Stenosis Progression | 000 | 5 | NIH | 8/21/2026 | $350,000 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM137921 | Mechanisms of mitochondrial subpopulation formation and maintenance | 001 | 6 | NIH | 3/13/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P30AR073750 | Oklahoma Rheumatic Disease Research Cores Center | 000 | 9 | NIH | 9/10/2026 | $852,500 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 000 | 8 | NIH | 5/25/2026 | $460,350 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DK085691 | Colon O-glycosylated mucus in the homeostasis of microbiota and host | 000 | 13 | NIH | 4/8/2026 | $731,770 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 001 | 2 | NIH | 3/25/2026 | $59,856 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 000 | 2 | NIH | 1/23/2026 | $538,719 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P30GM149376 | Expanding Excellence in Developmental Biology in Oklahoma | 000 | 4 | NIH | 6/23/2026 | $1,278,750 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R24OD034438 | Development of scalable methods for rapid phenotyping and functional testing of variants | 000 | 3 | NIH | 7/3/2026 | $616,207 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 001 | 4 | NIH | 4/16/2026 | $50,879 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 000 | 4 | NIH | 1/27/2026 | $457,898 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 002 | 2 | NIH | 8/14/2026 | $0 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 001 | 2 | NIH | 2/24/2026 | $0 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 000 | 2 | NIH | 12/10/2025 | $135,057 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI183676 | Defining the Regulatory Landscape of Lupus with CVD Comorbidity | 000 | 2 | NIH | 11/26/2025 | $847,133 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 001 | 4 | NIH | 3/13/2026 | $16,029 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 000 | 4 | NIH | 1/30/2026 | $507,628 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 000 | 4 | NIH | 4/10/2026 | $426,250 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL164854 | Roles of SARM1 NAD hydrolase in metabolic cardiomyopathy | 000 | 4 | NIH | 7/9/2026 | $604,146 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM147713 | The role of mitochondrial regulation in cell lineage specification and function | 000 | 5 | NIH | 6/11/2026 | $426,250 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL162985 | Metabolic mechanisms controlling lymphatic vessel formation | 000 | 5 | NIH | 8/3/2026 | $437,000 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 004 | 6 | NIH | 7/14/2026 | $2,557,500 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03NS147002 | Unraveling the roles of SLC25A22 and SLC25A46 in mitochondrial metabolism and neurological disorders | 000 | 1 | NIH | 9/11/2026 | $170,500 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01GM166726 | The role of SWI/SNF chromatin remodeling complexes in germ line transcription and nuclear organization | 000 | 1 | NIH | 9/3/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AG097386 | Dissecting amyloid β- and tau-mediated dopamine neuron deficits in Alzheimer's disease | 000 | 1 | NIH | 9/4/2026 | $65,271 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AI199564 | Regulation of disease progression and therapeutic response in multiple sclerosis by the gut microbiota | 000 | 1 | NIH | 7/9/2026 | $258,584 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL185377 | S1PR1 Signaling In The Lymphatic Vasculature Regulates Tertiary Lymphoid Organ Formation | 000 | 1 | NIH | 7/8/2026 | $676,865 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21EY037427 | Mechanistic investigations of tryptophan catabolites for vision improvement in Multiple Sclerosis | 000 | 1 | NIH | 4/17/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG099844 | Dissecting Inflammatory and Immune Mechanisms Driving Ovarian Tissue Aging | 002 | 1 | NIH | 4/21/2026 | $0 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG099844 | Dissecting Inflammatory and Immune Mechanisms Driving Ovarian Tissue Aging | 001 | 1 | NIH | 3/16/2026 | $48,231 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG099844 | Dissecting Inflammatory and Immune Mechanisms Driving Ovarian Tissue Aging | 000 | 1 | NIH | 3/6/2026 | $663,248 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DA062881 | Cell type-specific neurotensin signaling in methamphetamine use disorder | 000 | 1 | NIH | 2/6/2026 | $648,389 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21HD118636 | Homologous chromosome dynamics in mouse oocytes | 000 | 1 | NIH | 7/28/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R24OD040592 | Development of Precision Genome Editing Tools for the Functional Characterization of Genetic Variants | 000 | 1 | NIH | 6/19/2026 | $805,745 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AG093578 | Cell-type specific role of melanocortin 4 receptor in inflammation and cognition with aging | 001 | 2 | NIH | 3/9/2026 | $253,666 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03DE034789 | PDGFRbeta-mediated skeletal-vascular crosstalk in calvarial bone marrow development | 000 | 1 | NIH | 2/13/2026 | $341,000 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 000 | 4 | NIH | 2/27/2026 | $366,575 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM154839 | Novel pathways in heterochromatin regulation | 000 | 2 | NIH | 7/28/2026 | $426,250 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM160259 | Regulation of gene transcription and DNA replication by chromatin readers from the BET family | 000 | 2 | NIH | 5/5/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 000 | 8 | NIH | 5/22/2026 | $767,250 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL175157 | Understanding Sarcoidosis Susceptibility and Disease Burden Through Multi Omics | 000 | 2 | NIH | 7/15/2026 | $741,462 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AR086336 | Articular Microbiome for Prediction and Potential Therapy of Periprosthetic Joint Infections | 000 | 2 | NIH | 8/6/2026 | $104,732 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 002 | 3 | NIH | 3/31/2026 | $1,356 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 001 | 3 | NIH | 3/27/2026 | $83,224 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL101917 | Protease Activated Receptor and Thrombomodulin Signaling by coagulation proteases | 001 | 16 | NIH | 8/14/2026 | $417,725 |
|
